URT.WA
Price:
$38
Market Cap:
$53.57M
Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland.
Industry
Biotechnology
IPO Date
2021-10-27
Stock Exchange
WSE
Ticker
URT.WA
According to Urteste S.A.’s latest financial reports and current stock price. The company's current Current Ratio is 1.80. This represents a change of -79.98% compared to the average of 8.98 of the last 4 quarters.
The mean historical Current Ratio of Urteste S.A. over the last ten years is 23.04. The current 1.80 Current Ratio has changed 679.93% with respect to the historical average. Over the past ten years (40 quarters), URT.WA's Current Ratio was at its highest in in the September 2021 quarter at 216.34. The Current Ratio was at its lowest in in the June 2020 quarter at 0.
Average
23.04
Median
13.79
Minimum
5.72
Maximum
72.42
Discovering the peaks and valleys of Urteste S.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.17%
Maximum Annual Current Ratio = 72.42
Minimum Annual Increase = -69.37%
Minimum Annual Current Ratio = 5.72
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 10.33 | -40.11% |
| 2023 | 17.25 | 126.20% |
| 2022 | 7.63 | -69.37% |
| 2021 | 24.89 | -65.62% |
| 2020 | 72.42 | 1.17% |
The current Current Ratio of Urteste S.A. (URT.WA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.73
5-year avg
26.50
10-year avg
23.04
Urteste S.A.’s Current Ratio is less than Pharmena S.A. (13.52), greater than Pure Biologics Spólka Akcyjna (0.06), greater than Airway Medix S.A. (0.13), greater than NanoGroup S.A. (1.00), greater than BioMaxima S.A. (1.41), less than Genomtec S.A. (2.82), greater than Adiuvo Investments S.A. (0.03), less than Poltreg S.A. (3.09), less than Molecure S.A. (5.91), greater than Mabion S.A. (0.29),
| Company | Current Ratio | Market cap |
|---|---|---|
| 13.52 | $29.96M | |
| 0.06 | $27.60M | |
| 0.13 | $34.74M | |
| 1.00 | $84.75M | |
| 1.41 | $46.54M | |
| 2.82 | $55.06M | |
| 0.03 | $6.98M | |
| 3.09 | $119.38M | |
| 5.91 | $121.35M | |
| 0.29 | $110.39M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Urteste S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Urteste S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Urteste S.A.'s Current Ratio?
How is the Current Ratio calculated for Urteste S.A. (URT.WA)?
What is the highest Current Ratio for Urteste S.A. (URT.WA)?
What is the 3-year average Current Ratio for Urteste S.A. (URT.WA)?
What is the 5-year average Current Ratio for Urteste S.A. (URT.WA)?
How does the current Current Ratio for Urteste S.A. (URT.WA) compare to its historical average?